CACNB2 Antikörper (AA 565-579)
-
- Target Alle CACNB2 Antikörper anzeigen
- CACNB2 (Calcium Channel, Voltage-Dependent, beta 2 Subunit (CACNB2))
-
Bindungsspezifität
- AA 565-579
-
Reaktivität
- Human, Maus
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CACNB2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- CACNB2 (aa565-579)
- Sequenz
- ECNKQRSRHK SKDRY
- Spezifität
- This antibody is expected to recognize all reported isoforms (NP_000715.2, NP_963890.2, NP_963884.2, NP_963891.1, NP_963887.2, NP_963865.2, NP_963864.1, NP_963866.2, NP_001161417.1).
- Kreuzreaktivität
- Rind (Kuh), Hund, Human, Maus, Ratte
- Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Güteklasse
- Verified
- Immunogen
- Peptide with sequence ECNKQRSRHKSKDRY, from the C Terminus of the protein sequence according to NP_000715.2, NP_963890.2, NP_963884.2, NP_963891.1, NP_963887.2, NP_963865.2, NP_963864.1, NP_963866.2, NP_001161417.1.
- Isotyp
- IgG
- Top Product
- Discover our top product CACNB2 Primärantikörper
-
-
- Applikationshinweise
-
Western Blot: Approx 65 kDa band observed in lysates of cell lines NIH3T3 and Jurkat (calculated MW of 68.1 kDa according to NP_000715.2). Recommended concentration: 1-3 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:4000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Target
- CACNB2 (Calcium Channel, Voltage-Dependent, beta 2 Subunit (CACNB2))
- Andere Bezeichnung
- CACNB2 (CACNB2 Produkte)
- Synonyme
- CACNLB2 antikoerper, CAVB2 antikoerper, MYSB antikoerper, AW060387 antikoerper, CAB2 antikoerper, Cavbeta2 antikoerper, Cchb2 antikoerper, Cacnlb2 antikoerper, Cacnb2 antikoerper, CACNB2 antikoerper, CACNB2.2 antikoerper, cacnb2a antikoerper, im:7141271 antikoerper, si:dkey-32m20.2 antikoerper, calcium voltage-gated channel auxiliary subunit beta 2 antikoerper, calcium channel, voltage-dependent, beta 2 subunit antikoerper, calcium channel, voltage-dependent, beta 2b antikoerper, CACNB2 antikoerper, Cacnb2 antikoerper, cacnb2b antikoerper
- Hintergrund
- CACNB2, calcium channel, voltage-dependent, beta 2 subunit, CACNLB2, CAVB2, FLJ23743, MYSB, CAB2, calcium channel voltage-dependent subunit beta 2, lambert-Eaton myasthenic syndrome antigen B, myasthenic (Lambert-Eaton) syndrome antigen B, voltage-depende
- Gen-ID
- 783, 12296, 116600
- NCBI Accession
- NP_000715, NP_963890, NP_963884, NP_963891, NP_963887, NP_963865, NP_963864, NP_963866, NP_001161417
- Pathways
- Skeletal Muscle Fiber Development
-